Profil
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS. He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Aktiva positioner av Joël Richard
| Företag | Position | Start |
|---|---|---|
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Företagsledare/Principal | - |
Tidigare kända positioner av Joël Richard
| Företag | Position | Slut |
|---|---|---|
| MEDINCELL S.A. | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-01 |
| IPSEN | Företagsledare/Principal | - |
Ipsen Dreux | Företagsledare/Principal | - |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Verkställande Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 5 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Health Technology |
Ipsen Dreux |
















